The construct validity of the health utilities index mark 3 in assessing health status in lung transplantation

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Santana, Maria Jose ^a   Feeny, David ^b   Ghosh, Sunita ^c   Nador, Ronald G ^a   Weinkauf, Justin ^a   Jackson, Kathleen ^d   Schafenacker, Marianne ^d   Zuk, Dalyce ^a   Hubert, Grace ^d   Lien, Dale ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c CROSS CANCER INSTITUTE   (Canada)

^d UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONSTRUCT VALIDITY; CONTROLLED CLINICAL TRIAL; CORRELATION COEFFICIENT; DEPRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALBERTA; ANXIETY DISORDERS; CHRONIC DISEASE; DEPRESSIVE DISORDER; ETHNIC GROUPS; FEMALE; HEALTH STATUS; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 77957102809     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-110     Document Type: Article

References (49)

1. Gross CR, Savick K, Bolman RM, Hertz MI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest 1995, 108:1587-1593. 10.1378/chest.108.6.1587, 7497766.
2. Ten Vergert E, Essink-Bot ML, Geertsma A, et al. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 1998, 113:358-364. 10.1378/chest.113.2.358, 9498952.
3. Limbos M, Joyce D, Chan C, et al. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000, 118:408-416. 10.1378/chest.118.2.408, 10936133.
4. Lanuza D, Lefaiver C, McCabe M, et al. Prospective study of functional status and quality of life before and after lung transplantation. Chest 2000, 118:115-122. 10.1378/chest.118.1.115, 10893368.
5. Stavern K, Bjortuft O, Lund MB, et al. Health-related quality of life in lung transplant candidates and recipients. Respiration 2000, 67:159-165. 10.1159/000029480, 10773787.
6. Anyanwu AC, McGuire A, Rogers CA, et al. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax 2001, 56:218-222. 10.1136/thorax.56.3.218, 1758767, 11182015.
7. Gerbase MW, Spiliopoulos A, Rochat T, et al. Health-related quality of life following single or bilateral lung transplantation: A 7-year comparison to functional outcome. Chest 2005, 128:1371-1378. 10.1378/chest.128.3.1371, 16162731.
8. Singer L, Gould MK, Tomlinson G, Theodore J. Determinants of health utility in Lung and heart-lung transplant recipients. Am J Transpl 2005, 5:103-109.
9. Swigris JJ, Gould MK, Wilson SR. Health-Related Quality of Life Among Patients with Idiopathic Pulmonary Fibrosis. 2005, http://chestjournal.chestpubs.org/content/127/1/284.full.html
10. Santana MJ, Feeny D, Jackson K, Weinkauf J, Lien D. Improvement in health-related quality of life after lung transplantation. Can Respir J 2009, 16(5):153-158. 2779170, 19851533.
11. Ware JE. SF-36 Health survey: Manual and interpretation guide. 1993, Boston, MA: New England Medical Centre.
12. Ramsey SD, Patrick DL, Alberta RK, Larson EB, Woods DE, Raghu G. The cost-effectiveness of lung transplantation: pilot study. Chest 1995, 108:1594-601. 10.1378/chest.108.6.1594, 7497767.
13. Singer LG, Theodore J, Gould MK. Validity of standard gamble utilities as measured by transplant readiness in lung transplant. Med Decis Making 2003, 23:435-440. 10.1177/0272989X03258421, 14570301.
14. Torrance G, Feeny D, Furlong W, Barr RD, Zhang Y, Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care 1996, 34(7):702-22. 10.1097/00005650-199607000-00004, 8676608.
15. Feeny D, Furlong W, Torrance G, Goldsmith CH, Zhu Z, DePaw S, et al. Multi-attribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002, 40(2):113-128. 10.1097/00005650-200202000-00006, 11802084.
16. Kind P. The Euroqol instrument: an index of health-related quality of life. Quality of Life and Pharmacoeconomics in Clinical Trials 1996, Chapter 22:191-201. Philadelphia: Lippincott-Raven Press, Bert Spilker, Second.
17. Brazier JE, Roberts J. Estimating a preference-based index from the SF-12. Med Care 2004, 42(9):851-59. 10.1097/01.mlr.0000135827.18610.0d, 15319610.
18. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the Index of Well-Being. Health Serv Res 1976, 11:478-506. 1071947, 1030700.
19. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI®): concepts, measurement properties and applications. 2003, http://www.hqol.com/content/1/1/54
20. Statistics Canada National Population Health Survey Cycle 3 Documentation. Catalog #82-567., Statistics Canada.
21. Grootendorst P, Feeny D, Furlong W. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med Care 2000, 38(3):290-9. PubMed PMID: 10718354, 10.1097/00005650-200003000-00006, 10718354.
22. Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. J Rheumatol 2003, 30(10):2268-74. PubMed PMID: 14528528.
23. Maddigan SL, Feeny D, Johnson JA, . DOVE Investigators Construct validity ofthe RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes. Qual Life Res 2004, 13(2):435-48. PubMed PMID: 15085916, 10.1023/B:QURE.0000018497.06539.8f, 15085916, DOVE Investigators.
24. Blanchard C, Feeny D, Mahon JL, Bourne R, Rorabeck C, Stitt L, Webster-Bogaert S. Is the Health Utilities Index valid in total hip arthroplasty patients?. Qual Life Res 2004, 13(2):339-48. PubMed PMID: 15085906, 10.1023/B:QURE.0000018479.52075.bf, 15085906.
25. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 2005, 43(11):1078-86. PubMed PMID: 16224300, 10.1097/01.mlr.0000182493.57090.c1, 16224300.
26. Feeny D, Farris KB, Côté I, Johnson JA, Tsuyuki RT, Eng K. A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients. J Clin Epidemiol 2005, 58(2):138-41. PubMed PMID: 15680746, 10.1016/j.jclinepi.2004.08.005, 15680746.
27. Luo N, Seng BK, Thumboo J, Feeny D, Li SC. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia. Qual Life Res 2006, 15(5):889-98. PubMed PMID: 16721648, 10.1007/s11136-005-5745-8, 16721648.
28. Maddigan SL, Feeny D, Majumdar SR, Farris KB, Johnson JA. Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes. J Clin Epidemiol 2006, 59(5):472-7. Epub 2006 Mar 14. PubMed PMID: 16632135, 10.1016/j.jclinepi.2005.09.010, 16632135.
29. Welch KC, Scharf SM. Construct validity for the Health Utilities Index in a sleep center. Sleep Breath 2007, 11(4):295-303. PubMed PMID: 17457630, 10.1007/s11325-007-0111-4, 17457630.
30. Asakawa K, Rolfson D, Senthilselvan A, Feeny D, Johnson JA. Health Utilities Index Mark 3 showed valid in Alzheimer disease, arthritis, and cataracts. J Clin Epidemio 2008, 61:733-739.
31. Davidson S, Jhangri GS, Feeny D. Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease. Qual Life Res 2008, 17(6):933-942. 10.1007/s11136-008-9354-1, 18543076.
32. Feeny D, Huguet N, McFarland BH, Kaplan MS. The construct validity of the health utility index mark3 in assessing mental health in population health survey. Qual Life Res 2009, 18:519-526. 10.1007/s11136-009-9457-3, 19277898.
33. Santana MJ, Feeny D, Johnson JA, McAlister AF, Kim D, Weinkauf J, Lien D. Assessing the use of health-related quality of life measures in routine clinical care of lung-transplant patients. Qual Life Res 2010, 19(3):371-379. 10.1007/s11136-010-9599-3, 20146009.
34. Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med 2001, 33(5):344-349. 10.3109/07853890109002088, 11491193.
35. Smith GT, Fisher S, Fister SM. Incremental validity principles in test construction. Psychol Asses 2003, 15:467-477.
36. Shaw J, Johnson JA, Coons SJ. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model. Med Care 2005, 43(3):203-220. 10.1097/00005650-200503000-00003, 15725977.
37. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand 1983, 67(6):361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
38. Cohen J. Statistical Power Analysis for the Behavioural Sciences. 1988, Laurence Erlbaum, Hillsdale, NJ, 2.
39. Altman DG. Practical Statistics for medical research. 1991, London. Chapman & Hall.
40. SPSS, Chicago Illinois, USA Version 15, SPSS, Chicago Illinois, USA.
41. International Society for Heart and Lung Transplantation Last accessed 25 February 2010., International Society for Heart and Lung Transplantation., http://www.ishlt.org
42. American Thoraxic Society Statement Guidelines for the Six-Minute Walk Test. 2002, Last accessed 25 February 2010, American Thoraxic Society Statement., http://www.thoracic.org
43. American Thoraxic Society Standards for the diagnosis and care of patients with COPD Am J Resp Crit Care Med 1995, (5 Pt 2):S77-S121. American Thoraxic Society Standards for the diagnosis and care of patients with COPD.
44. Juniper EF, Guyatt GH, Feeny D, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in parents of children with asthma. Qual Life Res 1996, 5(1):27-34. 10.1007/BF00435966, 8901364.
45. Juniper EF, Guyatt GH, Feeny D, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996, 5(1):35-46. 10.1007/BF00435967, 8901365.
46. Guyatt GH, Juniper EF, Walters SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomized trials. Br Med J 1998, 316:690-693.
47. Hahn EA, Cella D, Chassany O, Fairclough DL, Wong GY, Hays RD, . the Clinical Significance Consensus Meeting Group Precision of health-related quality of life data compared with other clinical measures. Mayo Clin Proc 2007, 82(10):1244-1254. 10.4065/82.10.1244, 17908530, the Clinical Significance Consensus Meeting Group.
48. Furlong W, Feeny D, Torrance G, Barr R. The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies. Ann Med 2001, 33(5):375-384. 10.3109/07853890109002092, 11491197.
49. Feeny D. Preference-based measures: Utility and quality-adjusted life years. Assessing quality of life in clinical trials 2005, 405-429. Oxford: Oxford University Press, Fayers P, Hays R, 2.